President-elect takes swipe at pharma after Time “Person of the Year” accolade.
This week’s news
One Drop Chrome now available in US and EU thanks to FDA and CE mark approval.
Pfizer hiked price by 2600%, says competition watchdog.
Phase 3 trial supports Tagrisso as “standard of care” for some patients
Device allows those with neurodegenerative disorders to eat without spilling their food.
FDA and EMA hope to streamline development of paediatric plans.
Large trial of HIV PrEP could lead to national programme
Roche faces competition against its blockbuster haematology drug
Kite to start filing data for KTE-C19 with US regulator.
Study of nine patients produce encouraging results
Takeda joins with venture capital group to fund neuroscience research
But drug will not be funded for longer than two years.
Data protection regs will require better data management.